Stock comparison
HealthEquity
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HQY
HealthEquity
Market cap
$7.39B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HQY | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 64D | 77B | LMAT |
| Benjamin Graham | 69D | 89A | LMAT |
| Philip Fisher | 63C | 81C | LMAT |
| Peter Lynch | 60C | 67B | LMAT |
| Joel Greenblatt | 42D | 56D | LMAT |
| Charlie Munger | 59D | 68D | LMAT |
| Terry Smith | 62D | 69D | LMAT |
Side-by-side metrics
| Metric | HQY | LMAT |
|---|---|---|
| Market cap | $7.39B | $2.23B |
| P/E (TTM) | 32.7x | 37.1x |
| EV/EBIT | 23.5x | 36.6x |
| ROIC (TTM) | 7.61% | 9.43% |
| Gross margin | 69.52% | 72.39% |
| Net margin | 16.38% | 24.35% |
| Revenue CAGR 5y | 14.79% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 0.5x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HQY leads on
- Market cap$7.39Bvs $2.23B+70%
- EV/EBIT23.5xvs 36.6x+36%
- Revenue CAGR 5y14.79%vs 12.75%+14%
- P/E (TTM)32.7xvs 37.1x+12%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 16.38%+33%
- ROIC (TTM)9.43%vs 7.61%+19%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.